查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1741117

神经再生疗法市场：按神经再生疗法类型、适应症、给药方法、年龄层、最终用户和地区划分

Neuroregeneration Therapy Market, By Type of Neuroregeneration Therapy, By Indication, By Mode of Administration, By Age Group, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 161 Pages | 商品交期: 2-3个工作天内

价格
简介目录

神经再生治疗市场在2025年估计为147.7亿美元，预计到2032年将达到336.9亿美元，2025年至2032年的年复合成长率（CAGR）为12.5%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 147.7亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期：2025-2032年复合年增长率： 12.50% 2032年价值预测 336.9亿美元

神经再生是指神经组织（包括神经元、轴突、突触和神经胶质细胞）再生或修復的过程。这个过程对于修復因损伤而受损的组织并确保长期功能恢復至关重要。新的神经细胞和神经连接被合成，为受损神经细胞的替换提供新的资源。神经再生不仅是身体復健的重要机制，也是维持认知功能的重要机制。它在对抗记忆力障碍和与老龄化相关的异常方面发挥关键作用。神经再生的药物刺激可以恢復认知功能，并改善记忆力和其他认知能力。简而言之，神经再生是一个关键的生物学过程，对治疗各种神经系统疾病和促进大脑健康具有重要意义。

市场动态：

预计全球神经再生疗法市场在未来几年将显着成长，这主要得益于以下几个关键因素。首先，包括中枢和周边神经系统疾病在内的神经系统疾病盛行率不断上升，对有效安全的治疗方法的需求也随之增加。这些疾病会对患者的生活造成严重影响，因此神经再生疗法至关重要。其次，全球老化人口正在快速成长。老年人更容易患神经系统疾病，这进一步增加了对此类治疗方法的需求。随着人们寻求改善生活品质的治疗方法，神经再生疗法市场预计将扩大。最后，神经再生领域的研发活动激增。科学家和研究人员不断探索新的治疗方法，并在如何刺激神经组织修復和再生方面取得突破。这种持续的创新预计将为市场带来新的治疗方法，进一步推动成长。摘要，高疾病负担、人口老化以及积极的研发将推动全球神经再生疗法市场向前发展。

例如，2023年2月6日，生物技术公司Biogen Inc.和Sage Therapeutics, Inc.宣布，美国食品药物管理局(FDA)已接受新药认证用于治疗重度忧郁症(MDD)和产后忧郁症(PPD)的Zuranolone新药申请(NDA)。 Zuranolone是一种在临床实验药物，目前正在评估其作为每日一次、14天速效口服药物，用于治疗MDD和PPD成年患者。

本研究的主要特点

  • 本报告对全球神经再生治疗市场进行了详细分析，并以 2024 年为基准年，展示了预测期 2025 年至 2032 年的市场规模和复合年增长率。
  • 它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
  • 该报告涵盖了全球神经再生疗法市场的主要企业概况，基于以下参数，例如公司亮点、产品系列、主要亮点、财务表现和策略。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球神经再生疗法市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员将透过用于分析全球神经再生疗法市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

  • 市场动态
    • 神经系统疾病负担日益加重
    • 成本高且专业技术人员短缺
    • 安全有效治疗的需求很高
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

第四章全球神经再生疗法市场-冠状病毒（COVID-19）大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 全球神经再生疗法市场（依神经再生疗法类型划分），2020 年至 2032 年

  • 干细胞疗法
  • 基因治疗
  • 药物治疗
  • 神经刺激疗法
  • 其他的

6. 2020 年至 2032 年全球神经再生疗法市场（依适应症划分）

  • 脊髓损伤
  • 中风
  • 创伤性脑损伤
  • 帕金森氏症
  • 阿兹海默症
  • 多发性硬化症
  • 週边神经损伤
  • 其他的

7. 全球神经再生疗法市场（以交付方式），2020 年至 2032 年

  • 口服
  • 注射
  • 嵌入式
  • 其他的

8. 全球神经再生疗法市场（依年龄层划分），2020 年至 2032 年

  • 孩子们
  • 成人
  • 老年人

9. 全球神经再生疗法市场（按最终用户划分），2020 年至 2032 年

  • 医院
  • 专科诊所
  • 研究所
  • 復健中心
  • 其他的

第 10 章。 2020 年至 2032 年按地区分類的全球神经再生治疗市场

  • 北美洲
      • 美国
      • 加拿大
  • 欧洲
      • 德国
      • 英国
      • 西班牙
      • 法国
      • 义大利
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • 澳洲
      • 韩国
      • ASEAN
      • 其他亚太地区
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 中东
      • 海湾合作委员会国家
      • 以色列
      • 其他中东地区
  • 非洲
      • 南非
      • 北非
      • 中部非洲

第十一章竞争格局

  • Biogen Inc.
  • AstraZeneca PLC
  • Pfizer Inc.
  • Novartis International AG
  • Merck & Co., Inc.
  • Sanofi SA
  • F. Hoffmann-La Roche Ltd.
  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Ceregene Inc.
  • Lineage Cell Therapeutics, Inc.
  • Stemedica Cell Technologies, Inc.
  • StemCells Inc.
  • Ever Supreme Bio Technology Co., Ltd.
  • AbbVie

第十二章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5837

Neuroregeneration Therapy Market is estimated to be valued at USD 14.77 Bn in 2025 and is expected to reach USD 33.69 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 14.77 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 12.50% 2032 Value Projection: USD 33.69 Bn

Neuroregeneration refers to the process of regenerating or repairing nervous tissue, including neurons, axons, synapses, and glial cells. This process is crucial for replacing damaged tissues due to injury and ensuring long-term functional recovery. It involves the synthesis of new neurons and connections, providing additional resources to substitute the damaged ones. Neuroregeneration is not just about physical recovery; it's also a vital mechanism for maintaining cognitive functions. It plays a significant role in combating memory disorders and abnormalities related to aging. By pharmacologically stimulating neuroregeneration, it's possible to rescue cognitive functions, thereby improving memory and other cognitive abilities. In essence, neuroregeneration is a critical biological process with significant implications for treating various neurological conditions and improving brain health.

Market Dynamics:

The global neuroregeneration therapy market is expected to witness significant growth in the coming years, driven by several key factors. Firstly, the increasing prevalence of neurological disorders, including both central and peripheral nervous system disorders, is creating a high demand for effective and safe treatments. These disorders can have a debilitating impact on patients' lives, making the need for neuroregenerative therapies crucial. Secondly, the world's aging population is growing rapidly. Older individuals are more susceptible to neurological conditions, which further increases the demand for these therapies. As people seek treatments that can improve their quality of life, the market for neuroregeneration therapies is expected to expand. Lastly, there is a surge in research and development activities in the field of neuroregeneration. Scientists and researchers are continually exploring new treatment methods and making breakthroughs in understanding how to stimulate the repair and regrowth of nervous tissue. This ongoing innovation is expected to introduce new therapies to the market, driving further growth. In summary, the combination of a high disease burden, an aging population, and active research and development are set to propel the global neuroregeneration therapy market forward.

For instance, on February 6, 2023, Biogen Inc., a biotechnology company, and Sage Therapeutics, Inc., a biotechnology company, announced that the U.S. Food and Drug Administration (FDA) had accepted the filing of a New Drug Application (NDA) for zuranolone in the treatment of major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is an investigational drug being evaluated as a 14-day, rapid-acting, once-daily, oral treatment in adults with MDD and PPD.

Key features of the study:

  • This report provides in-depth analysis of the global neuroregeneration therapy market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global neuroregeneration therapy market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Biogen Inc., AstraZeneca PLC, Pfizer Inc., Novartis International AG, Merck & Co., Inc., Sanofi S.A., F. Hoffmann-La Roche Ltd., Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Ceregene Inc., Stemedica Cell Technologies, Inc., Lineage Cell Therapeutics, Inc., StemCells Inc., Ever Supreme Bio Technology Co., Ltd. and AbbVie
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global neuroregeneration therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuroregeneration therapy market

Detailed Segmentation:

  • By Type of Neuroregeneration Therapy:
    • Stem Cell Therapy
    • Gene Therapy
    • Pharmacological Therapy
    • Neurostimulation Therapy
    • Others
  • By Indication:
    • Spinal Cord Injury
    • Stroke
    • Traumatic Brain Injury
    • Parkinson's Disease
    • Alzheimer's Disease
    • Multiple Sclerosis
    • Peripheral Nerve Injury
    • Others
  • By Mode of Administration:
    • Oral
    • Injectable
    • Implantable
    • Others
  • By Age Group:
    • Pediatric
    • Adult
    • Geriatric
  • By End User:
    • Hospitals
    • Specialty Clinics
    • Research Institutes
    • Rehabilitation Centers
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Biogen Inc.
    • AstraZeneca PLC
    • Pfizer Inc.
    • Novartis International AG
    • Merck & Co., Inc.
    • Sanofi S.A.
    • F.Hoffmann-La Roche Ltd.
    • Medtronic plc
    • Boston Scientific Corporation
    • Abbott Laboratories
    • Ceregene Inc.
    • Lineage Cell Therapeutics, Inc.
    • Stemedica Cell Technologies, Inc.
    • StemCells Inc.
    • Ever Supreme Bio Technology Co., Ltd.
    • AbbVie

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type of Neuroregeneration Therapy
    • Market Snippet, By Indication
    • Market Snippet, By Mode of Administration
    • Market Snippet, By Age Group
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing burden of neurological disorders
    • High cost and dearth of skilled professionals
    • High demand for safe and effective therapeutics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Neuroregeneration Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Neuroregeneration Therapy Market, By Type of Neuroregeneration Therapy, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Stem Cell Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Gene Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Pharmacological Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Neurostimulation Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Neuroregeneration Therapy Market, By Indication, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Spinal Cord Injury
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Stroke
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Traumatic Brain Injury
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,( US$ Bn)
  • Parkinson's Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Alzheimer's Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Multiple Sclerosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032 ,(US$ Bn)
  • Peripheral Nerve Injury
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Neuroregeneration Therapy Market, By Mode of Administration, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Injectable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Implantable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Other
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Neuroregeneration Therapy Market, By Age Group, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Geriatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Neuroregeneration Therapy Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Rehabilitation Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

10. Global Neuroregeneration Therapy Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
      • South Africa
      • North Africa
      • Central Africa

11. Competitive Landscape

  • Biogen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AstraZeneca PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis International AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanofi S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • F. Hoffmann-La Roche Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ceregene Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lineage Cell Therapeutics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Stemedica Cell Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • StemCells Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ever Supreme Bio Technology Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AbbVie
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Analyst Views

12. Section

  • Research Methodology
  • About us